Nav: Home

Prestigious grant a 'coming of age' for CU Training Program in Cancer Biology

July 27, 2016

The Training Program in Cancer Biology (TPCB) partnering with the University of Colorado Cancer Center recently earned a prestigious National Cancer Institute T32 grant, funding PhD-level and post-doctoral training positions in cancer research. In addition to expanding the program's capacity and adding postdoctoral positions, this highly competitive grant recognizes the excellence of the program, which has grown to become a national leader in the interdisciplinary education of the next generation of cancer scientists.

"The best training programs are funded by these NCI T32 grants. Our award is a recognition of the outstanding research opportunities available for training in cancer biology at our institution," says Mary Reyland, PhD, TPCB program director, CU Cancer Center investigator and professor at the CU School of Dental Medicine. Reyland is co-principal investigator on the grant along with Scott Cramer, PhD, CU Cancer Center investigator and professor in the Department of Pharmacology at the CU School of Medicine. In addition to Drs. Reyland and Cramer, the TPCB training faculty includes 28 CU Cancer Center investigators with research interests in basic and translational cancer biology.

According to the National Cancer Institute, the goal of the T32 grant program is to "help ensure that a diverse and highly trained workforce is available to meet the needs of the Nation's biomedical, behavioral, and clinical research agenda," and to "prepare individuals for careers that will have a significant impact on the health-related research needs of the Nation." Programs accomplish these goals through a combination of mentoring and instruction, placing trainees in the laboratories of established cancer scientists.

"Our goal is to provide interdisciplinary training at the cutting edge of cancer research to best prepare our trainees to compete in a biomedical research environment increasingly focused on translational applications of basic research," Reyland says.

Despite major breakthroughs in our basic understanding of the cellular and molecular changes that lead to cancer, many key steps in carcinogenesis, and changes in early cancers that promote invasion and metastasis, still remain poorly defined. The TPCB, housed on the Anschutz Medical Campus in Aurora, Colorado, hopes to train the young researchers who will push forward the understanding of cancer biology and the new and evolving techniques used to study it.

"We hope to enhance recruitment and training of the best and brightest junior scientists who are passionate about careers as independent scientists or physician scientists," Reyland says.

Previously, the program was limited to PhD students. The new grant expands the program's scope, adding postdoctoral positions. "It enables us to support and develop trainees at a more advanced stage that will more quickly become leaders in cancer research," Reyland says.

Reyland, Cramer and program faculty are currently evaluating applications from PhD-level and post-doctoral researchers.
-end-


University of Colorado Anschutz Medical Campus

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...